We are live on ! Find out more
VIRS

Pacer BioThreat Strategy ETF
VIRS

Delisted

VIRS was delisted on the 10th of October, 2024.

Back to rankings

4 hedge funds and large institutions have $1.6M invested in Pacer BioThreat Strategy ETF in 2023 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

9.6% more ownership

Funds ownership: 40.05% → 49.65% (+9.6%)

3% more capital invested

Capital invested by funds: $1.55M → $1.6M (+$51.7K)

0% more funds holding

Funds holding: 4 → 4 (0)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

Holders
4
Holders Change
–
Holders Change %
0%
% of All Funds
0.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
IAIM
International Assets Investment Management
Florida
+$572K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$83.7K
3
UBS Group
UBS Group
Switzerland
+$18.4K

Top Sellers

Rank Fund Capital Flow
1
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$658K
2
Osaic Holdings
Osaic Holdings
Arizona
-$82.3K

VIRS Hedge Fund Activity: Q4 2023 in Review

4 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in Pacer BioThreat Strategy ETF (VIRS) for Q4 2023, worth a combined $1.6M — up 3.3% from $1.55M a quarter earlier.

Fund positioning in VIRS was balanced in Q4 2023: 1 fund opened new positions, 1 closed out, 2 added to existing stakes and 1 trimmed.

The largest buyer was International Assets Investment Management, opening a new position worth an estimated $572K. The largest seller was Royal Bank of Canada, exiting entirely with an estimated $658K sold.

  • 4 institutional investors held Pacer BioThreat Strategy ETF (VIRS) as of Q4 2023, unchanged from Q3 2023.
  • Funds reported $1.6M of Pacer BioThreat Strategy ETF stock for Q4 2023, up 3.3% quarter-over-quarter.
  • 1 fund opened new Pacer BioThreat Strategy ETF positions in Q4 2023 and 1 closed out, a net change of 0 holders.
  • The largest Pacer BioThreat Strategy ETF buyer in Q4 2023 was International Assets Investment Management, an estimated $572K added.
  • The largest Pacer BioThreat Strategy ETF seller in Q4 2023 was Royal Bank of Canada, an estimated $658K sold.

Based on aggregated 13F filings for Q4 2023.